Target intelligence / Profile preview

Bronchi

01

Overview

The bronchi are the primary air passages of the lower respiratory tract, branching from the trachea and leading into the lungs to facilitate gas exchange (StatPearls, 'Anatomy, Thorax, Bronchi'). Anatomically, they are complex tissue structures composed of smooth muscle, hyaline cartilage, and a ciliated respiratory epithelium, rather than a specific molecular target like a single protein or enzyme (Wikipedia, 'Bronchus'). In the field of respiratory medicine, the bronchi serve as the physiological site of action for numerous inhaled therapies aimed at managing obstructive diseases like asthma and COPD (NIH, 'Asthma'). These medications exert their effects by interacting with specific molecular receptors found within the bronchial walls, such as the beta-2 adrenergic receptor (ADRB2) for bronchodilation or the glucocorticoid receptor for anti-inflammatory effects (PubMed, 'Pharmacology of airway smooth muscle'). Pathological changes in the bronchi, including inflammation, mucus hypersecretion, and remodeling, are hallmarks of chronic respiratory conditions (Cleveland Clinic, 'Bronchi'). Because 'Bronchi' refers to an anatomical structure and not a molecular entity, it is considered an incorrect designation for a therapeutic target in a structured molecular database.

Other names
Bronchial tubesBronchusTracheobronchial tree
02

Mechanism of action

Pharmacological interventions in the bronchi typically involve the activation of beta-2 adrenergic receptors to relax smooth muscle or the antagonism of muscarinic receptors to prevent bronchoconstriction; corticosteroids are also used to suppress mucosal inflammation.

03

Biological functions

Air conduction to and from the lung parenchymaAir filtration and trapping of particles via mucusMucociliary clearance of pathogens and debrisHumidification and warming of inspired air
04

Disease associations

AsthmaChronic obstructive pulmonary disease (COPD)Acute and chronic bronchitisBronchiectasisCystic fibrosisLung cancer
05

Safety considerations

Paradoxical bronchospasmSystemic absorption of inhaled corticosteroids causing adrenal suppressionTachycardia and tremors from systemic beta-agonist exposureOropharyngeal candidiasis (thrush)
06

Interacting drugs

Albuterol

6 more in the full profile.

07

Biomarkers

Forced Expiratory Volume in 1 second (FEV1)Peak Expiratory Flow (PEF)Fractional exhaled nitric oxide (FeNO)Sputum eosinophils

Beyond the preview

Go deeper on Bronchi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bronchi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call